Most edited pathways

Showing below up to 500 results starting with #51.

View (previous 500) (next 500) (20 | 50 | 100 | 250 | 500)

51. Homo sapiens:Energy metabolism ‎(71 revisions)
52. Rattus norvegicus:Renin-angiotensin system ‎(70 revisions)
53. Homo sapiens:Degradation pathway of sphingolipids, including diseases ‎(70 revisions)
54. Homo sapiens:Linoleic acid metabolism affected by SARS-CoV-2 ‎(69 revisions)
55. Homo sapiens:Androgen receptor network in prostate cancer ‎(69 revisions)
56. Homo sapiens:Glycerophospholipid biosynthetic pathway ‎(68 revisions)
57. Arabidopsis thaliana:Long-day flowering time pathway ‎(67 revisions)
58. Homo sapiens:Eicosanoid synthesis ‎(67 revisions)
59. Homo sapiens:Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism ‎(67 revisions)
60. Homo sapiens:Omega-6-fatty acids in senescence ‎(66 revisions)
61. Homo sapiens:Physiological and pathological hypertrophy of the heart ‎(65 revisions)
62. Homo sapiens:Biosynthesis and regeneration of tetrahydrobiopterin and catabolism of phenylalanine ‎(64 revisions)
63. Homo sapiens:Pleural mesothelioma ‎(64 revisions)
64. Homo sapiens:Disorders in ketone body synthesis ‎(64 revisions)
65. Homo sapiens:Disorders of bile acid synthesis and biliary transport ‎(64 revisions)
66. Homo sapiens:Methionine metabolism leading to sulfur amino acids and related disorders ‎(63 revisions)
67. Homo sapiens:MicroRNAs in cardiomyocyte hypertrophy ‎(63 revisions)
68. Homo sapiens:MAPK signaling pathway ‎(63 revisions)
69. Homo sapiens:Cell cycle ‎(63 revisions)
70. Homo sapiens:TP53 network ‎(62 revisions)
71. Homo sapiens:Target of rapamycin signaling ‎(62 revisions)
72. Homo sapiens:Alanine and aspartate metabolism ‎(61 revisions)
73. Homo sapiens:Type II diabetes mellitus ‎(61 revisions)
74. Homo sapiens:Prostaglandin synthesis and regulation ‎(61 revisions)
75. Homo sapiens:Electron transport chain: OXPHOS system in mitochondria ‎(61 revisions)
76. Homo sapiens:miRNAs involved in DNA damage response ‎(60 revisions)
77. Homo sapiens:Sphingolipid pathway ‎(60 revisions)
78. Homo sapiens:Vitamin B6-dependent and responsive disorders ‎(60 revisions)
79. Homo sapiens:Mitochondrial immune response to SARS-CoV-2 ‎(60 revisions)
80. Homo sapiens:Irinotecan pathway ‎(60 revisions)
81. Homo sapiens:Cholesterol synthesis disorders ‎(60 revisions)
82. Homo sapiens:Liver steatosis adverse outcome pathway ‎(60 revisions)
83. Homo sapiens:Vitamin B12 disorders ‎(60 revisions)
84. Homo sapiens:Wnt signaling pathway and pluripotency ‎(59 revisions)
85. Homo sapiens:Estrogen signaling pathway ‎(59 revisions)
86. Caenorhabditis elegans:Male mating ‎(59 revisions)
87. Homo sapiens:PDGF pathway ‎(59 revisions)
88. Homo sapiens:Angiogenesis ‎(59 revisions)
89. Mus musculus:Ptf1a related regulatory pathway ‎(58 revisions)
90. Homo sapiens:Angiogenesis overview ‎(58 revisions)
91. Homo sapiens:Glycosylation and related congenital defects ‎(58 revisions)
92. Homo sapiens:Metabolic pathways of fibroblasts ‎(58 revisions)
93. Homo sapiens:Glioblastoma signaling pathways ‎(58 revisions)
94. Homo sapiens:Chronic hyperglycemia impairment of neuron function ‎(58 revisions)
95. Homo sapiens:Fluoropyrimidine activity ‎(58 revisions)
96. Homo sapiens:Neurotransmitter disorders ‎(58 revisions)
97. Homo sapiens:ACE inhibitor pathway ‎(58 revisions)
98. Arabidopsis thaliana:Flavonoid pathway ‎(57 revisions)
99. Homo sapiens:Spinal cord injury ‎(57 revisions)
100. Homo sapiens:Selenium metabolism and selenoproteins ‎(57 revisions)
101. Homo sapiens:DNA damage response (only ATM dependent) ‎(57 revisions)
102. Homo sapiens:Aerobic glycolysis ‎(57 revisions)
103. Homo sapiens:Thyroxine (thyroid hormone) production ‎(56 revisions)
104. Homo sapiens:Tamoxifen metabolism ‎(56 revisions)
105. Homo sapiens:Iron metabolism in placenta ‎(55 revisions)
106. Homo sapiens:Myometrial relaxation and contraction pathways ‎(55 revisions)
107. Homo sapiens:GABA metabolism (aka GHB) ‎(54 revisions)
108. Homo sapiens:T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection ‎(54 revisions)
109. Homo sapiens:Fatty acid beta-oxidation ‎(54 revisions)
110. Homo sapiens:Ether lipid biosynthesis ‎(54 revisions)
111. Mus musculus:Amino acid metabolism ‎(54 revisions)
112. Danio rerio:Fin development ‎(53 revisions)
113. Homo sapiens:Lung fibrosis ‎(53 revisions)
114. Homo sapiens:Apoptosis ‎(53 revisions)
115. Homo sapiens:Calcium regulation in cardiac cells ‎(52 revisions)
116. Homo sapiens:22q11.2 copy number variation syndrome ‎(52 revisions)
117. Homo sapiens:Wnt signaling pathway ‎(51 revisions)
118. Homo sapiens:AMP-activated protein kinase signaling ‎(51 revisions)
119. Homo sapiens:Apoptosis modulation and signaling ‎(51 revisions)
120. Saccharomyces cerevisiae:Tricarboxylic acid cycle ‎(51 revisions)
121. Mus musculus:Splicing factor NOVA regulated synaptic proteins ‎(51 revisions)
122. Caenorhabditis elegans:Aging ‎(51 revisions)
123. Homo sapiens:Endoplasmic reticulum stress response in coronavirus infection ‎(51 revisions)
124. Homo sapiens:Hemesynthesis defects and porphyrias ‎(50 revisions)
125. Rattus norvegicus:p53 pathway ‎(50 revisions)
126. Homo sapiens:Leucine, isoleucine and valine metabolism ‎(50 revisions)
127. Homo sapiens:Melatonin metabolism and effects ‎(50 revisions)
128. Homo sapiens:Blood clotting cascade ‎(50 revisions)
129. Homo sapiens:Cholesterol biosynthesis pathway ‎(50 revisions)
130. Homo sapiens:Prader-Willi and Angelman syndrome ‎(49 revisions)
131. Mus musculus:Serotonin and anxiety ‎(49 revisions)
132. Danio rerio:FGF signaling pathway ‎(49 revisions)
133. Homo sapiens:Type I interferon induction and signaling during SARS-CoV-2 infection ‎(49 revisions)
134. Homo sapiens:VEGFA-VEGFR2 signaling ‎(49 revisions)
135. Homo sapiens:Ciliopathies ‎(49 revisions)
136. Homo sapiens:SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction ‎(49 revisions)
137. Homo sapiens:Disorders of folate metabolism and transport ‎(49 revisions)
138. Homo sapiens:Triacylglyceride synthesis ‎(48 revisions)
139. Homo sapiens:Catalytic cycle of mammalian flavin-containing monooxygenases (FMOs) ‎(48 revisions)
140. Homo sapiens:Wnt signaling ‎(48 revisions)
141. Homo sapiens:Cerebral organic acidurias, including diseases ‎(48 revisions)
142. Homo sapiens:Involvement of δ-secretase in neurodegenerative diseases ‎(48 revisions)
143. Homo sapiens:Acute viral myocarditis ‎(48 revisions)
144. Homo sapiens:Regulation of actin cytoskeleton ‎(47 revisions)
145. Homo sapiens:Fatty acid biosynthesis ‎(47 revisions)
146. Gallus gallus:Chicken limb development ‎(47 revisions)
147. Homo sapiens:Metapathway biotransformation Phase I and II ‎(47 revisions)
148. Rattus norvegicus:Relationship between glutathione and NADPH ‎(47 revisions)
149. Homo sapiens:Synaptic vesicle pathway ‎(47 revisions)
150. Homo sapiens:Tyrosine metabolism and related disorders ‎(47 revisions)
151. Mus musculus:Distal convoluted tubule 1 (DCT1) cell ‎(46 revisions)
152. Homo sapiens:MECP2 and associated Rett syndrome ‎(46 revisions)
153. Escherichia coli:SK UDPglcnac ‎(46 revisions)
154. Homo sapiens:Parkinson's disease pathway ‎(46 revisions)
155. Homo sapiens:Cytokines and inflammatory response ‎(46 revisions)
156. Homo sapiens:Focal adhesion ‎(45 revisions)
157. Homo sapiens:Estrogen metabolism ‎(45 revisions)
158. Rattus norvegicus:Fructose metabolism in proximal tubules ‎(45 revisions)
159. Mus musculus:ESC pluripotency pathways ‎(45 revisions)
160. Homo sapiens:Complement activation ‎(45 revisions)
161. Homo sapiens:Oxidation by cytochrome P450 ‎(45 revisions)
162. Homo sapiens:Prion disease pathway ‎(45 revisions)
163. Saccharomyces cerevisiae:Filamentous growth pathway ‎(45 revisions)
164. Homo sapiens:Glyoxylate metabolism ‎(45 revisions)
165. Homo sapiens:Extrafollicular and follicular B cell activation by SARS-CoV-2 ‎(45 revisions)
166. Homo sapiens:Fas ligand pathway and stress induction of heat shock proteins ‎(44 revisions)
167. Homo sapiens:Disorders of fructose metabolism ‎(44 revisions)
168. Homo sapiens:Methionine de novo and salvage pathway ‎(44 revisions)
169. Homo sapiens:Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases ‎(44 revisions)
170. Homo sapiens:Pathogenic Escherichia coli infection ‎(44 revisions)
171. Homo sapiens:Histone modifications ‎(44 revisions)
172. Homo sapiens:Ferroptosis ‎(44 revisions)
173. Homo sapiens:COVID-19, thrombosis and anticoagulation ‎(44 revisions)
174. Homo sapiens:MTHFR deficiency ‎(44 revisions)
175. Homo sapiens:T-cell activation SARS-CoV-2 ‎(44 revisions)
176. Homo sapiens:Nanomaterial induced apoptosis ‎(43 revisions)
177. Rattus norvegicus:Proximal tubule transporters ‎(43 revisions)
178. Homo sapiens:Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway ‎(43 revisions)
179. Danio rerio:Canonical wnt signaling ‎(43 revisions)
180. Homo sapiens:Disorders of galactose metabolism ‎(43 revisions)
181. Rattus norvegicus:Genetic alterations of lung cancer ‎(43 revisions)
182. Homo sapiens:7q11.23 copy number variation syndrome ‎(42 revisions)
183. Homo sapiens:Nicotine effect on dopaminergic neurons ‎(42 revisions)
184. Homo sapiens:DIV ‎(42 revisions)
185. Homo sapiens:G1 to S cell cycle control ‎(42 revisions)
186. Homo sapiens:Microtubule cytoskeleton regulation ‎(42 revisions)
187. Mycobacterium tuberculosis:Citrate cycle (TCA cycle) ‎(42 revisions)
188. Mus musculus:Limb development ‎(42 revisions)
189. Homo sapiens:TGF-beta signaling pathway ‎(42 revisions)
190. Homo sapiens:Complement and coagulation cascades ‎(42 revisions)
191. Caenorhabditis elegans:Vulval development ‎(42 revisions)
192. Rattus norvegicus:Hexoses metabolism in proximal tubules ‎(42 revisions)
193. Homo sapiens:Riboflavin and CoQ disorders ‎(42 revisions)
194. Homo sapiens:Gastric acid production ‎(42 revisions)
195. Homo sapiens:Oxidative stress response ‎(42 revisions)
196. Homo sapiens:Metabolism of sphingolipids in ER and Golgi apparatus ‎(41 revisions)
197. Homo sapiens:Insulin signaling ‎(41 revisions)
198. Homo sapiens:Biosynthesis and turnover of 1-deoxy-sphingoid bases ‎(41 revisions)
199. Homo sapiens:Trans-sulfuration, one-carbon metabolism and related pathways ‎(41 revisions)
200. Homo sapiens:Nuclear receptors meta-pathway ‎(40 revisions)
201. Homo sapiens:Monoamine GPCRs ‎(40 revisions)
202. Homo sapiens:Inflammatory bowel disease signaling ‎(40 revisions)
203. Homo sapiens:Creatine pathway ‎(40 revisions)
204. Mus musculus:One-carbon metabolism ‎(40 revisions)
205. Homo sapiens:Integrated cancer pathway ‎(40 revisions)
206. Homo sapiens:GPCRs, class A rhodopsin-like ‎(40 revisions)
207. Zea mays:Vitamin B1 (thiamin) biosynthesis and salvage pathway ‎(40 revisions)
208. Homo sapiens:Immune infiltration in pancreatic cancer ‎(40 revisions)
209. Homo sapiens:Toll-like receptor signaling pathway ‎(40 revisions)
210. Homo sapiens:Polycystic kidney disease pathway ‎(39 revisions)
211. Homo sapiens:Osteoblast signaling ‎(39 revisions)
212. Homo sapiens:Bladder cancer ‎(39 revisions)
213. Homo sapiens:Chromosomal and microsatellite instability in colorectal cancer ‎(39 revisions)
214. Rattus norvegicus:Alanine and aspartate metabolism ‎(39 revisions)
215. Homo sapiens:Ovarian infertility ‎(39 revisions)
216. Homo sapiens:Estradiol regulation in porto-sinusoidal vascular disease ‎(39 revisions)
217. Homo sapiens:IL-1 signaling pathway ‎(39 revisions)
218. Homo sapiens:Meta pathway lipodystrophy, dyslipidemia and hyperlipidemia ‎(39 revisions)
219. Mus musculus:Eicosanoid metabolism via cyclooxygenases (COX) ‎(38 revisions)
220. Homo sapiens:Overlap between signal transduction pathways contributing to LMNA laminopathies ‎(38 revisions)
221. Homo sapiens:Transcriptional activation by NRF2 in response to phytochemicals ‎(38 revisions)
222. Homo sapiens:Cori cycle ‎(38 revisions)
223. Homo sapiens:Krebs cycle disorders ‎(38 revisions)
224. Mus musculus:Elongation of (very) long chain fatty acids ‎(38 revisions)
225. Homo sapiens:Resolvin E1 and resolvin D1 signaling decrease inflammation ‎(38 revisions)
226. Mycobacterium tuberculosis:Biotin metabolism ‎(38 revisions)
227. Homo sapiens:Mevalonate arm of cholesterol biosynthesis pathway ‎(38 revisions)
228. Rattus norvegicus:Glycolysis and gluconeogenesis ‎(38 revisions)
229. Homo sapiens:Vitamin K metabolism and activation of dependent proteins ‎(38 revisions)
230. Homo sapiens:Mammary gland development: pregnancy and lactation - stage 3 of 4 ‎(38 revisions)
231. Saccharomyces cerevisiae:Pentose phosphate pathway 2 ‎(38 revisions)
232. Homo sapiens:Osteoclast signaling ‎(38 revisions)
233. Homo sapiens:Prostaglandin and leukotriene metabolism in senescence ‎(37 revisions)
234. Homo sapiens:DNA replication ‎(37 revisions)
235. Homo sapiens:Female steroid hormones in cardiomyocyte energy metabolism ‎(37 revisions)
236. Homo sapiens:Urea cycle and related diseases ‎(37 revisions)
237. Homo sapiens:Gastric cancer network 1 ‎(37 revisions)
238. Homo sapiens:TNF-alpha signaling pathway ‎(37 revisions)
239. Homo sapiens:Acetylcholine synthesis ‎(37 revisions)
240. Rattus norvegicus:Fatty acid beta-oxidation ‎(37 revisions)
241. Homo sapiens:Osteoarthritic chondrocyte hypertrophy ‎(37 revisions)
242. Homo sapiens:PtdIns(4,5)P2 in cytokinesis pathway ‎(37 revisions)
243. Homo sapiens:Thyroid stimulating hormone (TSH) signaling pathway ‎(37 revisions)
244. Homo sapiens:Urea cycle and associated pathways ‎(37 revisions)
245. Homo sapiens:mRNA processing ‎(37 revisions)
246. Homo sapiens:TGF-beta receptor signaling ‎(37 revisions)
247. Homo sapiens:Peptide GPCRs ‎(37 revisions)
248. Homo sapiens:Spina bifida ‎(37 revisions)
249. Homo sapiens:Nod-like receptor (NLR) signaling pathway ‎(37 revisions)
250. Homo sapiens:Endometrial cancer ‎(37 revisions)
251. Homo sapiens:Proteasome degradation ‎(36 revisions)
252. Homo sapiens:Growth factors and hormones in beta cell proliferation ‎(36 revisions)
253. Homo sapiens:Leukotriene metabolic pathway ‎(36 revisions)
254. Homo sapiens:Codeine and morphine metabolism ‎(36 revisions)
255. Homo sapiens:Nuclear receptors in lipid metabolism and toxicity ‎(36 revisions)
256. Homo sapiens:Downregulation of ACE2 by SARS-CoV-2 spike protein ‎(36 revisions)
257. Homo sapiens:DYRK1A involvement regarding cell proliferation in brain development ‎(36 revisions)
258. Homo sapiens:Biogenic amine synthesis ‎(36 revisions)
259. Homo sapiens:Cysteine and methionine catabolism ‎(36 revisions)
260. Homo sapiens:MAPK cascade ‎(36 revisions)
261. Homo sapiens:Alternative pathway of fetal androgen synthesis ‎(36 revisions)
262. Homo sapiens:Physico-chemical features and toxicity-associated pathways ‎(36 revisions)
263. Homo sapiens:Arylamine metabolism ‎(36 revisions)
264. Homo sapiens:Biotin metabolism, including IMDs ‎(35 revisions)
265. Mus musculus:Folic acid network ‎(35 revisions)
266. Homo sapiens:Sulfatase and aromatase pathway ‎(35 revisions)
267. Homo sapiens:Serotonin receptor 4/6/7 and NR3C signaling ‎(35 revisions)
268. Mus musculus:Regulation of cardiac hypertrophy by miR-208 ‎(35 revisions)
269. Homo sapiens:IL6 signaling pathway ‎(35 revisions)
270. Homo sapiens:Measles virus infection ‎(35 revisions)
271. Homo sapiens:Oxidative phosphorylation ‎(35 revisions)
272. Rattus norvegicus:p53 signal pathway ‎(35 revisions)
273. Gibberella zeae:DON mycotoxin biosynthesis ‎(35 revisions)
274. Rattus norvegicus:Cholesterol metabolism ‎(35 revisions)
275. Homo sapiens:DNA mismatch repair ‎(35 revisions)
276. Homo sapiens:TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc) ‎(35 revisions)
277. Arabidopsis thaliana:Flowering time pathway ‎(35 revisions)
278. Homo sapiens:Hijack of ubiquitination by SARS-CoV-2 ‎(35 revisions)
279. Homo sapiens:Nicotine metabolism in liver cells ‎(35 revisions)
280. Homo sapiens:Heme biosynthesis ‎(35 revisions)
281. Mus musculus:Glycolysis and gluconeogenesis ‎(35 revisions)
282. Homo sapiens:G protein signaling pathways ‎(34 revisions)
283. Homo sapiens:Non-homologous end joining ‎(34 revisions)
284. Homo sapiens:Primary focal segmental glomerulosclerosis (FSGS) ‎(34 revisions)
285. Homo sapiens:Regulation of toll-like receptor signaling pathway ‎(34 revisions)
286. Mus musculus:Statin pathway ‎(34 revisions)
287. Homo sapiens:IL-7 signaling pathway ‎(34 revisions)
288. Mus musculus:GPCRs, other ‎(34 revisions)
289. Homo sapiens:IL-2 signaling pathway ‎(34 revisions)
290. Homo sapiens:7-oxo-C and 7-beta-HC pathways ‎(34 revisions)
291. Rattus norvegicus:Catecholamine synthesis ‎(34 revisions)
292. Homo sapiens:IL-4 signaling pathway ‎(34 revisions)
293. Homo sapiens:Aflatoxin B1 metabolism ‎(34 revisions)
294. Homo sapiens:Sulfation biotransformation reaction ‎(34 revisions)
295. Homo sapiens:Head and neck squamous cell carcinoma ‎(34 revisions)
296. Homo sapiens:Steroid biosynthesis ‎(34 revisions)
297. Homo sapiens:Eukaryotic transcription initiation ‎(34 revisions)
298. Homo sapiens:Pentose phosphate metabolism ‎(34 revisions)
299. Mus musculus:Calcium regulation in cardiac cells ‎(34 revisions)
300. Homo sapiens:Glycogen synthesis and degradation ‎(34 revisions)
301. Homo sapiens:SARS-CoV-2 innate immunity evasion and cell-specific immune response ‎(34 revisions)
302. Homo sapiens:T cell modulation in pancreatic cancer ‎(34 revisions)
303. Homo sapiens:Notch signaling ‎(34 revisions)
304. Homo sapiens:Apoptosis modulation by HSP70 ‎(33 revisions)
305. Mus musculus:Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling ‎(33 revisions)
306. Homo sapiens:Serine metabolism ‎(33 revisions)
307. Plasmodium falciparum:Isoprenoid precursor biosynthesis in Pf apicoplasts ‎(33 revisions)
308. Rattus norvegicus:VEGF-receptor signal transduction ‎(33 revisions)
309. Homo sapiens:Angiotensin II receptor type 1 pathway ‎(33 revisions)
310. Homo sapiens:Roles of ceramides in development of insulin resistance ‎(33 revisions)
311. Homo sapiens:Androgen receptor signaling pathway ‎(33 revisions)
312. Caenorhabditis elegans:Metapathway signal transduction ‎(33 revisions)
313. Homo sapiens:Cardiac progenitor differentiation ‎(33 revisions)
314. Saccharomyces cerevisiae:Phosphatidic acid and phospholipid biosynthesis ‎(33 revisions)
315. Homo sapiens:Nanoparticle triggered regulated necrosis ‎(33 revisions)
316. Mus musculus:Glutathione and one-carbon metabolism ‎(33 revisions)
317. Homo sapiens:Aerobic glycolysis - simplified ‎(33 revisions)
318. Mycobacterium tuberculosis:D-arginine and D-ornithine metabolism ‎(33 revisions)
319. Homo sapiens:EGF/EGFR signaling pathway ‎(33 revisions)
320. Homo sapiens:Affected pathways in Duchenne muscular dystrophy ‎(33 revisions)
321. Arabidopsis thaliana:Plant primary metabolism ‎(32 revisions)
322. Homo sapiens:AXL signaling pathway ‎(32 revisions)
323. Saccharomyces cerevisiae:High-osmolarity glycerol (HOG) pathway ‎(32 revisions)
324. Homo sapiens:Breast cancer pathway ‎(32 revisions)
325. Homo sapiens:Host-pathogen interaction of human coronaviruses - MAPK signaling ‎(32 revisions)
326. Homo sapiens:Glutathione metabolism ‎(32 revisions)
327. Mus musculus:Focal adhesion ‎(32 revisions)
328. Homo sapiens:Hypothesized pathways in pathogenesis of cardiovascular disease ‎(32 revisions)
329. Homo sapiens:Glucuronidation ‎(32 revisions)
330. Homo sapiens:Angiopoietin-like protein 8 regulatory pathway ‎(32 revisions)
331. Homo sapiens:RAS and bradykinin pathways in COVID-19 ‎(32 revisions)
332. Mus musculus:Microglia pathogen phagocytosis pathway ‎(32 revisions)
333. Homo sapiens:Cell-type dependent selectivity of CCK2R signaling ‎(32 revisions)
334. Saccharomyces cerevisiae:Glycolysis and gluconeogenesis ‎(32 revisions)
335. Zea mays:Vitamin B3 (niacin), NAD and NADP biosynthesis pathway ‎(32 revisions)
336. Homo sapiens:Ebola virus infection in host ‎(32 revisions)
337. Drosophila melanogaster:Fatty acid biosynthesis ‎(32 revisions)
338. Homo sapiens:Mitochondrial long chain fatty acid beta-oxidation ‎(32 revisions)
339. Homo sapiens:B cell receptor signaling pathway ‎(32 revisions)
340. Rattus norvegicus:ATM signaling pathway ‎(32 revisions)
341. Homo sapiens:Inflammatory response pathway ‎(31 revisions)
342. Homo sapiens:Endochondral ossification with skeletal dysplasias ‎(31 revisions)
343. Homo sapiens:Oligodendrocyte specification and differentiation, leading to myelin components for CNS ‎(31 revisions)
344. Mus musculus:GPCRs, class A rhodopsin-like ‎(31 revisions)
345. Homo sapiens:Formation of Fibrin Clot and the Clotting Cascade ‎(31 revisions)
346. Homo sapiens:Rett syndrome ‎(31 revisions)
347. Mus musculus:Electron transport chain ‎(31 revisions)
348. Homo sapiens:G13 signaling pathway ‎(31 revisions)
349. Homo sapiens:Corticotropin-releasing hormone signaling pathway ‎(31 revisions)
350. Homo sapiens:Gastric cancer network 2 ‎(31 revisions)
351. Homo sapiens:Cell cycle checkpoints ‎(31 revisions)
352. Gallus gallus:Toll-like receptor pathway ‎(31 revisions)
353. Anopheles gambiae:GPCR-Calcium ‎(31 revisions)
354. Caenorhabditis elegans:Crystal toxin triggered necrosis pathway ‎(31 revisions)
355. Homo sapiens:Endochondral ossification ‎(31 revisions)
356. Homo sapiens:3q29 copy number variation syndrome ‎(31 revisions)
357. Mus musculus:Selenium micronutrient network ‎(31 revisions)
358. Homo sapiens:MET in type 1 papillary renal cell carcinoma ‎(31 revisions)
359. Mus musculus:Serotonin and anxiety-related events ‎(30 revisions)
360. Rattus norvegicus:Pentose phosphate pathway ‎(30 revisions)
361. Homo sapiens:Thiamine metabolic pathways ‎(30 revisions)
362. Saccharomyces cerevisiae:Crabtree effect ‎(30 revisions)
363. Homo sapiens:Alpha 6 beta 4 signaling pathway ‎(30 revisions)
364. Homo sapiens:Notch signaling pathway ‎(30 revisions)
365. Saccharomyces cerevisiae:TCA cycle ‎(30 revisions)
366. Anopheles gambiae:testing testing ‎(30 revisions)
367. Mus musculus:Tyrobp causal network in microglia ‎(30 revisions)
368. Homo sapiens:Small ligand GPCRs ‎(30 revisions)
369. Homo sapiens:Prostaglandin signaling ‎(30 revisions)
370. Homo sapiens:Glial cell differentiation ‎(30 revisions)
371. Mus musculus:Tryptophan metabolism ‎(30 revisions)
372. Zea mays:Vitamin B5 (pantothenate) and CoA biosynthesis Pathway ‎(30 revisions)
373. Mus musculus:Glucocorticoid and mineralcorticoid metabolism ‎(30 revisions)
374. Homo sapiens:Urea cycle and metabolism of amino groups ‎(30 revisions)
375. Homo sapiens:Flavan-3-ol metabolic pathway ‎(30 revisions)
376. Oryza sativa:Seed development ‎(30 revisions)
377. Homo sapiens:Dravet syndrome ‎(30 revisions)
378. Drosophila melanogaster:Toll, IMD, JAK/STAT pathways for immune response to pathogens ‎(30 revisions)
379. Homo sapiens:EGFR tyrosine kinase inhibitor resistance ‎(30 revisions)
380. Homo sapiens:NRP1-triggered signaling pathways in pancreatic cancer ‎(30 revisions)
381. Homo sapiens:GPCRs, other ‎(29 revisions)
382. Saccharomyces cerevisiae:MAPK signaling pathway ‎(29 revisions)
383. Homo sapiens:Cholesterol biosynthesis ‎(29 revisions)
384. Homo sapiens:Proline and hydroxyproline pathways ‎(29 revisions)
385. Zea mays:Vitamin B9 (folate) biosynthesis pathway ‎(29 revisions)
386. Homo sapiens:Mineralocorticoid biosynthesis ‎(29 revisions)
387. Homo sapiens:Phase I biotransformations, non-P450 ‎(29 revisions)
388. Rattus norvegicus:Thick ascending limb transporters ‎(29 revisions)
389. Homo sapiens:Major receptors targeted by epinephrine and norepinephrine ‎(29 revisions)
390. Homo sapiens:16p11.2 proximal deletion syndrome ‎(29 revisions)
391. Rattus norvegicus:Electron transport chain ‎(29 revisions)
392. Rattus norvegicus:Angiotensin II signaling (acute) in thick ascending limbs ‎(29 revisions)
393. Homo sapiens:Familial partial lipodystrophy ‎(29 revisions)
394. Oryza sativa:Octadecanoid pathway ‎(29 revisions)
395. Danio rerio:Nodal signaling pathway ‎(29 revisions)
396. Mus musculus:Mecp2 and associated Rett syndrome ‎(29 revisions)
397. Homo sapiens:Dopamine metabolism ‎(29 revisions)
398. Homo sapiens:Hedgehog signaling pathway ‎(29 revisions)
399. Homo sapiens:Pilocytic astrocytoma ‎(29 revisions)
400. Homo sapiens:Hepatocyte growth factor receptor signaling ‎(29 revisions)
401. Homo sapiens:SARS-CoV-2 and ACE2 receptor: molecular mechanisms ‎(29 revisions)
402. Homo sapiens:Molybdenum cofactor (Moco) biosynthesis ‎(29 revisions)
403. Homo sapiens:FGFR3 signaling in chondrocyte proliferation and terminal differentiation ‎(29 revisions)
404. Homo sapiens:CAMKK2 pathway ‎(29 revisions)
405. Saccharomyces cerevisiae:Glucose repression ‎(29 revisions)
406. Homo sapiens:PI3K/AKT/mTOR - vitamin D3 signaling ‎(29 revisions)
407. Mus musculus:Myometrial relaxation and contraction pathways ‎(29 revisions)
408. Rattus norvegicus:Wnt myofibroblastic activation of hepatic stellate cells ‎(28 revisions)
409. Rattus norvegicus:Folic acid network ‎(28 revisions)
410. Saccharomyces cerevisiae:Glucose-1-phosphate metabolism ‎(28 revisions)
411. Homo sapiens:Response to elevated platelet cytosolic Ca ions ‎(28 revisions)
412. Homo sapiens:NAD metabolism, sirtuins and aging ‎(28 revisions)
413. Homo sapiens:Thyroid hormones production and peripheral downstream signaling effects ‎(28 revisions)
414. Mus musculus:Primary focal segmental glomerulosclerosis (FSGS) ‎(28 revisions)
415. Homo sapiens:IL-17 signaling pathway ‎(28 revisions)
416. Mus musculus:Deregulation of renin-angiotensin system by SARS-CoV infection ‎(28 revisions)
417. Homo sapiens:Clear cell renal cell carcinoma pathways ‎(28 revisions)
418. Homo sapiens:Axon guidance ‎(28 revisions)
419. Homo sapiens:TCA cycle nutrient use and invasiveness of ovarian cancer ‎(28 revisions)
420. Caenorhabditis elegans:TCA cycle ‎(28 revisions)
421. Homo sapiens:Amino acid conjugation of benzoic acid ‎(28 revisions)
422. Homo sapiens:p38 MAPK signaling pathway ‎(28 revisions)
423. Homo sapiens:Vitamin D receptor pathway ‎(28 revisions)
424. Arabidopsis thaliana:2-acetyl-1-pyrroline pathway ‎(28 revisions)
425. Homo sapiens:IL-5 signaling pathway ‎(28 revisions)
426. Mus musculus:Dopaminergic neurogenesis ‎(28 revisions)
427. Homo sapiens:PI3K-AKT-mTOR signaling and therapeutic opportunities in prostate cancer ‎(28 revisions)
428. Escherichia coli:Escherichia coli K-12 peripherome ‎(28 revisions)
429. Homo sapiens:Calcium mediated T-cell apoptosis involved in inclusion body myositis ‎(28 revisions)
430. Homo sapiens:Hair follicle development: induction - stage 1 of 3 ‎(28 revisions)
431. Mus musculus:Wnt signaling in kidney disease ‎(28 revisions)
432. Homo sapiens:Non-small cell lung cancer ‎(28 revisions)
433. Caenorhabditis elegans:Cell engulfment ‎(28 revisions)
434. Homo sapiens:Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway ‎(28 revisions)
435. Rattus norvegicus:NFE2L2 ‎(28 revisions)
436. Homo sapiens:Cell interactions of the pancreatic cancer microenvironment ‎(28 revisions)
437. Homo sapiens:Pyrimidine metabolism ‎(28 revisions)
438. Homo sapiens:IL-9 signaling pathway ‎(28 revisions)
439. Homo sapiens:Parkin-ubiquitin proteasomal system pathway ‎(28 revisions)
440. Homo sapiens:Nucleotide metabolism ‎(28 revisions)
441. Homo sapiens:Aryl hydrocarbon receptor pathway ‎(28 revisions)
442. Homo sapiens:S1P receptor signal transduction ‎(28 revisions)
443. Homo sapiens:Serotonin receptor 2 and ELK-SRF/GATA4 signaling ‎(28 revisions)
444. Homo sapiens:Transport of glycerol from adipocytes to liver by aquaporins ‎(28 revisions)
445. Homo sapiens:4-hydroxytamoxifen, dexamethasone, and retinoic acids regulation of p27 expression ‎(28 revisions)
446. Mus musculus:Purine metabolism ‎(27 revisions)
447. Rattus norvegicus:Glucocorticoid effect on target gene expression ‎(27 revisions)
448. Homo sapiens:Alstrom syndrome ‎(27 revisions)
449. Homo sapiens:RANKL/RANK signaling pathway ‎(27 revisions)
450. Mus musculus:Chemokine signaling pathway ‎(27 revisions)
451. Homo sapiens:Benzo(a)pyrene metabolism ‎(27 revisions)
452. Homo sapiens:Folate-alcohol and cancer pathway hypotheses ‎(27 revisions)
453. Homo sapiens:Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins ‎(27 revisions)
454. Bos taurus:Folate metabolism ‎(27 revisions)
455. Mycobacterium tuberculosis:Lipoic acid metabolism ‎(27 revisions)
456. Homo sapiens:Polyol pathway ‎(27 revisions)
457. Homo sapiens:Integrin-mediated cell adhesion ‎(27 revisions)
458. Arabidopsis thaliana:Kaempferol derivatives ‎(27 revisions)
459. Homo sapiens:Amino acid transport defects (IEMs) ‎(27 revisions)
460. Homo sapiens:Ulcerative colitis signaling ‎(27 revisions)
461. Homo sapiens:Mitochondrial beta-oxidation ‎(27 revisions)
462. Mus musculus:Focal adhesion: PI3K-Akt-mTOR signaling pathway ‎(27 revisions)
463. Homo sapiens:Carnosine metabolism of glial cells ‎(27 revisions)
464. Danio rerio:TCA cycle ‎(27 revisions)
465. Homo sapiens:Cannabinoid receptor signaling ‎(27 revisions)
466. Mus musculus:Mapk signaling pathway ‎(27 revisions)
467. Homo sapiens:Ganglio sphingolipid metabolism ‎(27 revisions)
468. Homo sapiens:Lactate shuttle in glial cells ‎(27 revisions)
469. Homo sapiens:Eukaryotic translation initiation ‎(27 revisions)
470. Homo sapiens:Common pathways underlying drug addiction ‎(27 revisions)
471. Homo sapiens:Post-translational modification: synthesis of GPI-anchored proteins ‎(27 revisions)
472. Homo sapiens:Sphingolipid metabolism in senescence ‎(27 revisions)
473. Homo sapiens:Opioid signaling ‎(27 revisions)
474. Homo sapiens:SRF and miRs in smooth muscle differentiation and proliferation ‎(27 revisions)
475. Homo sapiens:Focal adhesion: PI3K-Akt-mTOR-signaling pathway ‎(27 revisions)
476. Homo sapiens:Epigallocatechin-3-O-gallate / epigallocatechin / epicatechin breakdown pathway ‎(26 revisions)
477. Danio rerio:BMP signaling pathway ‎(26 revisions)
478. Rattus norvegicus:Triacylglyceride synthesis ‎(26 revisions)
479. Homo sapiens:Pluripotent stem cell differentiation pathway ‎(26 revisions)
480. Homo sapiens:GNAQ pathways in port-wine stain ‎(26 revisions)
481. Homo sapiens:Activation of gene expression by SREBF (SREBP) ‎(26 revisions)
482. Homo sapiens:Regulation of apoptosis by parathyroid hormone-related protein ‎(26 revisions)
483. Rattus norvegicus:Irinotecan pathway ‎(26 revisions)
484. Mus musculus:Adar1 editing defficiency immune response ‎(26 revisions)
485. Homo sapiens:Nephrotoxcicity adverse outcome pathway ‎(26 revisions)
486. Homo sapiens:Steroid hormone precursor biosynthesis ‎(26 revisions)
487. Homo sapiens:Integration of energy metabolism ‎(26 revisions)
488. Homo sapiens:Ras signaling ‎(26 revisions)
489. Homo sapiens:miR-targeted genes in leukocytes ‎(26 revisions)
490. Mus musculus:FAS pathway and stress induction of HSP regulation ‎(26 revisions)
491. Homo sapiens:Copper homeostasis ‎(26 revisions)
492. Homo sapiens:Copper metabolism ‎(26 revisions)
493. Homo sapiens:Apoptotic execution phase ‎(26 revisions)
494. Homo sapiens:Exercise-induced circadian regulation ‎(26 revisions)
495. Homo sapiens:MicroRNAs in cardiomyocyte hypertrophy 2 ‎(26 revisions)
496. Homo sapiens:Pathways affected in adenoid cystic carcinoma ‎(26 revisions)
497. Mus musculus:Eicosanoid metabolism via lipoxygenases (LOX) ‎(26 revisions)
498. Homo sapiens:IL-3 signaling pathway ‎(26 revisions)
499. Homo sapiens:Rap1 signaling ‎(26 revisions)
500. Homo sapiens:Cell division cycle 27 ‎(26 revisions)
501. Mus musculus:Mapk cascade ‎(26 revisions)
502. Homo sapiens:Fatty acid omega-oxidation ‎(26 revisions)
503. Homo sapiens:Hair follicle development: cytodifferentiation - stage 3 of 3 ‎(26 revisions)
504. Mus musculus:Notch signaling pathway ‎(26 revisions)
505. Homo sapiens:Signaling by VEGF ‎(26 revisions)
506. Arabidopsis thaliana:Genetic interactions between sugar and hormone signaling ‎(26 revisions)
507. Homo sapiens:GPCRs, class B secretin-like ‎(26 revisions)
508. Homo sapiens:Interleukin-1 family signaling ‎(26 revisions)
509. Homo sapiens:Metabolism of nitric oxide: NOS3 activation and regulation ‎(26 revisions)
510. Homo sapiens:Nucleosome assembly ‎(26 revisions)
511. Homo sapiens:Platelet homeostasis ‎(26 revisions)
512. Homo sapiens:Striated muscle contraction pathway ‎(26 revisions)
513. Homo sapiens:Neovascularization processes ‎(26 revisions)
514. Homo sapiens:Metabolic epileptic disorders ‎(26 revisions)
515. Homo sapiens:Metabolism of porphyrins ‎(26 revisions)
516. Homo sapiens:Influence of laminopathies on Wnt signaling ‎(26 revisions)
517. Rattus norvegicus:Fatty acid biosynthesis ‎(25 revisions)
518. Homo sapiens:Arrhythmogenic right ventricular cardiomyopathy ‎(25 revisions)
519. Homo sapiens:Mitotic G1 phase and G1/S transition ‎(25 revisions)
520. Homo sapiens:Phosphodiesterases in neuronal function ‎(25 revisions)
521. Oryza sativa:Flowering time pathway ‎(25 revisions)
522. Homo sapiens:Pathways of nucleic acid metabolism and innate immune sensing ‎(25 revisions)
523. Homo sapiens:Kinesins ‎(25 revisions)
524. Homo sapiens:Influenza Infection ‎(25 revisions)
525. Rattus norvegicus:VEGFR-3 signaling ‎(25 revisions)
526. Rattus norvegicus:TCA cycle ‎(25 revisions)
527. Homo sapiens:Hair follicle development: organogenesis - stage 2 of 3 ‎(25 revisions)
528. Homo sapiens:Osteopontin signaling ‎(25 revisions)
529. Homo sapiens:T-cell receptor signaling pathway ‎(25 revisions)
530. Homo sapiens:Methylation pathways ‎(25 revisions)
531. Homo sapiens:Thrombin signaling through proteinase activated receptors (PARs) ‎(25 revisions)
532. Homo sapiens:Mitochondrial gene expression ‎(25 revisions)
533. Homo sapiens:Hepatitis B infection ‎(25 revisions)
534. Homo sapiens:Nanoparticle triggered autophagic cell death ‎(25 revisions)
535. Arabidopsis thaliana:Flower development ‎(25 revisions)
536. Homo sapiens:Asparagine N-linked glycosylation ‎(25 revisions)
537. Danio rerio:MAPK signaling pathway ‎(25 revisions)
538. Homo sapiens:Neurotransmitter uptake and metabolism In glial cells ‎(25 revisions)
539. Homo sapiens:Platelet adhesion to exposed collagen ‎(25 revisions)
540. Homo sapiens:Fcgamma receptor (FCGR) dependent phagocytosis ‎(25 revisions)
541. Rattus norvegicus:Cardiovascular signaling ‎(25 revisions)
542. Homo sapiens:LDL- influence on CD14 and TLR4 ‎(25 revisions)
543. Homo sapiens:Glucocorticoid biosynthesis ‎(25 revisions)
544. Homo sapiens:Bile acid and bile salt metabolism ‎(25 revisions)
545. Homo sapiens:Regulation of apoptosis ‎(25 revisions)
546. Homo sapiens:Signal amplification ‎(25 revisions)

View (previous 500) (next 500) (20 | 50 | 100 | 250 | 500)